Maruti Suzuki inaugurates Kharkhoda plant, 0.5 million units now, 1 million planned
Maruti Suzuki India · Automobiles
Key highlights
- Kharkhoda facility spread over 800 acres with integrated supplier park; current capacity 0.5 million units; projected total investment INR 35,000 crore
- Capacity to scale up to 1 million units; company expects 2.9 million units total capacity by FY 2026-27 after commissioning of fourth Hansalpur plant
- 100% of electricity met through renewable energy with 20 MWp installed solar; biogas plant and battery storage being installed; creating over 21,000 jobs
Why it's rated major development: amount is ₹10,000 crore or more
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Maruti Suzuki India
- Capex / expansionNotableMaruti Suzuki India Limited announces Annual Integrated Report 2025-26 and growth updates
- Capex / expansionNotableMaruti Suzuki India begins commercial production at fourth Hansalpur plant, Gujarat
- Capex / expansionNotableMaruti Suzuki commences commercial production at second Kharkhoda plant
- Capex / expansionMajor developmentMaruti Suzuki India approves first phase capacity addition of 2.5 lakh vehicles at Khoraj
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Automobiles
on management's own guidance
- M & MGood growth2
- Strong growth1
- Bajaj AutoGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.